Potassium deficiency can set the stage for rhabdomyolysis, a severe form of muscle breakdown, because chronically low potassium impairs normal muscle metabolism, contraction, and blood-flow regulation during exertion. In potassium‑depleted muscle, exercise normally meant to trigger local potassium‑mediated vasodilation instead occurs on a background of blunted blood‑flow increase and relative ischemia, which can tip active fibers toward cramps, fiber necrosis, and release of muscle enzymes such as creatine kinase and myoglobin. Case reports describe patients with profound hypokalemia from causes like primary aldosteronism, short‑bowel–related losses, or periodic paralysis presenting with weakness, dark “cola‑colored” urine, and very high creatine kinase levels, often improving after aggressive potassium repletion and hydration, highlighting that low potassium can be a hidden, correctable driver of non‑traumatic rhabdomyolysis. This medication is commonly used for Hypertension.
Jain VV, Gupta OP, Jajoo SU, Khiangate B. Hypokalemia induced rhabdomyolysis. Indian J Nephrol. 2011 Jan;21(1):66. Chung-Tso Chen, et al. Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases. Am J Case Rep 2021; 22:e929758. He R, Guo WJ, She F, Miao GB, Liu F, Xue YJ, Liu YW, Wang HT, Zhang P. A rare case of hypokalemia-induced rhabdomyolysis. J Geriatr Cardiol. 2018 Apr;15(4):321-324. Dimitrios J. Antoniadis, et al. Rhabdomyolysis Due to Diuretic Treatment. Hellenic J Cardiol 44: 80-82, 2003.
Some side effects may be linked to nutrient depletion caused by this medication.
Thiamine (vitamin B1) deficiency in patients with cardiovascular disease might be linked to two factors associated with loop diuretics: increased urine output, and cellular uptake inhibition. Loop diuretics can significantly increase urine volume and urinary flow rate, potentially leading to increased thiamine excretion through urine. Emerging evidence suggests loop diuretics may directly inhibit the cellular uptake of thiamine, further contributing to deficiency. Thiamine supplementation during loop diuretic therapy should therefore be considered.
Long-term use with Loop diuretics can come with potential side effects related to nutrient depletion. One such essential nutrient that these medications can impact is potassium. Potassium plays a critical role in various bodily functions including regulating blood pressure, ensuring proper balance of fluids and electrolytes within cells, and may contribute to a lower risk of developing kidney stones and bone loss. Potassium supplementation during loop diuretic therapy should therefore be considered.
Studies indicate that Loop diuretics can act as folate antagonists, potentially leading to a deficiency. This occurs because some diuretics inhibit the enzyme responsible for utilizing folate (folic acid) in the body. Research suggests a link between long-term diuretic use (over six months) and decreased blood folate levels while also showing a significant increase in damaging homocysteine levels. Folate supplementation during loop diuretic therapy should therefore be considered.
Loop diuretics can disrupt the kidneys' ability to reabsorb magnesium, leading to increased excretion of this essential mineral through urine. This potential depletion necessitates monitoring magnesium levels, especially in individuals undergoing long-term loop diuretic therapy. Supplementing with magnesium may be beneficial in such cases to help protect against a deficiency.
Calcium, crucial for strong bones and teeth, can be depleted by loop diuretics. These medications can unfortunately decrease calcium levels in the body. To protect against a deficiency and maintain optimal bone health, individuals taking loop diuretics may benefit from calcium supplementation.